Clinical trials recruiting for Primary Aldosteronism

Phase breakdown

Drugs and treatments being studied

Where trials are recruiting (top US states)

Top cities

Self-screener

Recruiting trials

• Cardiovascular Manifestations of MR Activation in Primary Aldosteronism: Pilot Clinical Study
  NCT05030545 · Phase: Phase 4 · Ages: 18 Years to 85 Years · Sex: All (male and female) · 1 location
• Comparison of Catecholamine Concentrations in Venous Blood During Selective Adrenal Artery Embolization
  NCT06228677 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Diagnosing Variable Primary Aldosteronism.
  NCT05765786 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Effects of Adrenal Artery Ablation and Spironolactone in Patients With Primary Aldosteronism
  NCT04409431 · Phase: Not applicable (e.g. observational or device study) · Ages: 30 Years to 60 Years · Sex: All (male and female) · 1 location
• Efficacy and Safety of Finerenone Compared to Spironolactone in Treatment of Primary Aldosteronism
  NCT07688928 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Efficacy of Spironolactone Combined With Antihypertensive Drugs in Patients With Primary Aldosteronism
  NCT07137364 · Phase: Not specified · Ages: 30 Years to 65 Years · Sex: All (male and female) · 1 location
• Overnight Dexamethasone in Primary Aldosteronism Screening
  NCT06740838 · Phase: Not specified · Ages: 40 Years to 75 Years · Sex: All (male and female) · 1 location
• PETAL Trial: Impact of Gallium-68 Pentixafor PET-CT on Surgical Outcomes in Primary Aldosteronism
  NCT07027254 · Phase: Not applicable (e.g. observational or device study) · Ages: 19 Years and older · Sex: All (male and female) · 2 locations
• Statin Combined with Amlodipine Treats Primary Aldosteronism
  NCT06523465 · Phase: Phase 4 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• Steroids-Based Screening for Primary Aldosteronism
  NCT06941116 · Phase: Not specified · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Tissue Sodium Quantification in Patients With Primary Aldosteronism: See Sodium to Treat
  NCT06569589 · Phase: Not specified · Ages: 21 Years to 70 Years · Sex: All (male and female) · 4 locations

Related conditions

Trials recruiting for Primary Aldosteronism often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Primary Aldosteronism trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.